Tipifarnib
Showing 1 - 25 of 92
Advanced Solid Tumor Trial in Canton, Austin, San Antonio (Tipifarnib)
Recruiting
- Advanced Solid Tumor
- Tipifarnib
-
Canton, Ohio
- +2 more
Aug 19, 2022
HRAS Mutations or Peripheral T Cell Lymphoma (PTCL) Trial (Tipifarnib)
Available
- HRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
- Tipifarnib
- (no location specified)
Jun 7, 2022
Urothelial Carcinoma Trial in Seoul (tipifarnib)
Active, not recruiting
- Urothelial Carcinoma
- tipifarnib
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 6, 2022
Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)
Active, not recruiting
- Non Small Cell Lung Cancer
- Tipifarnib
-
Santiago De Compostela, A Coruña, Spain
- +29 more
Sep 21, 2022
Leukemia, Myelomonocytic, Chronic Trial in United States (Tipifarnib)
Completed
- Leukemia, Myelomonocytic, Chronic
- Tipifarnib
-
Scottsdale, Arizona
- +7 more
May 12, 2021
Relapsed or Refractory Peripheral T-Cell Lymphoma Trial in Korea, Republic of, Spain, United States (Tipifarnib)
Completed
- Relapsed or Refractory Peripheral T-Cell Lymphoma
- Tipifarnib
-
Palo Alto, California
- +12 more
Apr 26, 2021
Thyroid Cancer, Squamous Cell Carcinoma Head Neck Cancer (HNSCC), HRAS Mutant Tumor Trial in Worldwide (Tipifarnib)
Completed
- Thyroid Cancer
- +3 more
- Tipifarnib
-
Los Angeles, California
- +34 more
May 12, 2021
Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (gemcitabine HCl,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +3 more
-
Philadelphia, PennsylvaniaRadiation Therapy Oncology Group
Oct 29, 2020
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
Pancreatic Cancer Trial in Philadelphia (tipifarnib, radiation therapy)
Completed
- Pancreatic Cancer
- tipifarnib
- radiation therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 13, 2020
MDS Trial in Boston, New York (Tipifarnib)
Terminated
- Myelodysplastic Syndromes
- Tipifarnib
-
Boston, Massachusetts
- +1 more
Jan 30, 2020
Anaplastic Large Cell Lymphoma, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Mature T-Cell and
Completed
- Anaplastic Large Cell Lymphoma
- +12 more
- Laboratory Biomarker Analysis
- Tipifarnib
-
Iowa City, Iowa
- +1 more
Apr 3, 2020
HRAS Gene Mutation, HNSCC Trial in Worldwide (Tipifarnib, HRAS Detection Assay)
Recruiting
- HRAS Gene Mutation
- HNSCC
- Tipifarnib
- HRAS Detection Assay
-
Los Angeles, California
- +131 more
Feb 24, 2021
MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)
Recruiting
- MDS/MPN
- Azacitidine (AZA) with Ruxolitinib
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023
Leukemia Trial in Iowa City, Baltimore, Rochester (tipifarnib)
Completed
- Leukemia
- tipifarnib
-
Iowa City, Iowa
- +2 more
Nov 5, 2019
Lung Cancer Trial in Philadelphia (carboplatin, paclitaxel, tipifarnib)
Completed
- Lung Cancer
- carboplatin
- +3 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 12, 2019
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer Trial in Bronx (fulvestrant,
Completed
- Estrogen Receptor-positive Breast Cancer
- +4 more
- fulvestrant
- tipifarnib
-
Bronx, New YorkMontefiore Medical Center
Oct 4, 2018
Neurofibromatosis Type 1, Plexiform Neurofibroma Trial in United States (Binimetinib)
Active, not recruiting
- Neurofibromatosis Type 1
- Plexiform Neurofibroma
-
Birmingham, Alabama
- +21 more
Dec 4, 2021
Mantle Cell Lymphoma Trial (ZARNESTRA (Tipifarnib))
Terminated
- Mantle Cell Lymphoma
- ZARNESTRA (Tipifarnib)
- (no location specified)
Aug 21, 2018
Accelerated Phase of Disease, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelogenous Leukemia, BCR-ABL1
Completed
- Accelerated Phase of Disease
- +6 more
- Laboratory Biomarker Analysis
- Tipifarnib
-
Palo Alto, California
- +1 more
May 31, 2018
Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study)
Completed
- Solid Neoplasm
- Erlotinib Hydrochloride
- +3 more
-
Rochester, MinnesotaMayo Clinic
May 17, 2018